// App-Quantinova.ai

: Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

Researchers

Presenter

  • Krzysztof Madry

Principal Investigators

  • Karol Lis

  • Pierre Fenaux

  • David Bowen

  • Argiris Symeonidis

  • Moshe Mittelman

  • Reinhard Stauder

  • Jaroslav Cermak

  • Guillermo Sanz

  • Eva Hellstrm-Lindberg

  • Luca Malcovati

  • Saskia Langemeijer

  • Ulrich Germing

  • Mette Skov Holm

  • Agns Guerci-Bresler

  • Dominic Culligan

  • Laurence Sanhes

  • Juliet Mills

  • Ioannis Kotsianidis

  • Corine van Marrewijk

  • Simon Crouch

  • Theo M de Witte

  • Alexandra Smith

Medical Centers

  • Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warszawa, Poland

  • Epidemiology&Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom

  • Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warszawa, Poland

  • Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7,Paris,France

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • Internal diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Rheumatology Department, Hospital Universitari i Politecnic la Fe, Valencia, Spain

  • Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden

  • Department of Molecular Medicine & Hematology Oncology, Piazzale Golgi 2, Italy

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Hematology, Oncology and Clinical Immunology, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany,

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Service d'Hématologie, Centre Hospitalier Universtaire Brabois, Vandoeuvre-lès-Nancy, France

  • Dept of Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Service d'Hématologie, Centre Hospitalier de Perpignan, Perpignan, FRA

  • Hematology,Acute Hospitals NHS Trust and University of Birmingham,Birmingham,United Kingdom

  • University General Hospital of Alexandroupoli, Alexandroupoli, Greece

  • Epidemiology and Cancer Statistics Group, Department of Health Sciences,University of York,York,United Kingdom

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

  • University of York, York, United Kingdom.

Locations

  • Poland

  • United Kingdom

  • France

  • Greece

  • Israel

  • Austria

  • Czech Republic

  • Spain

  • Sweden

  • Italy

  • Netherlands

  • Germany

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved